Skip to main content
. 2021 Dec 13;10(24):5837. doi: 10.3390/jcm10245837

Figure 1.

Figure 1

Differences in C-reactive protein (CRP) levels among patients with systemic lupus erythematosus (SLE) stratified based on the presence of detectable interleukin 6 (IL-6) levels, Type I interferon (IFN) gene signature, and CRP-lowering gene polymorphism (rs1205), respectively. All patients had a low disease activity but could be serologically active at sampling. Bars indicate median values. Dots represent individual values. Data shown in the figure were adopted from Enocsson et al. [115], with permission from Frontiers Media, 2021 (Creative Commons Attribution licence, version 4.0).